Stocks and Investing Stocks and Investing
Fri, November 18, 2022

Anupam Rama Maintained (ANAB) at Sell with Increased Target to $32 on, Nov 18th, 2022


Published on 2024-10-28 00:15:38 - WOPRAI, Anupam Rama
  Print publication without navigation


Anupam Rama of JP Morgan, Maintained "AnaptysBio, Inc." (ANAB) at Sell with Increased Target from $24 to $32 on, Nov 18th, 2022.

Anupam has made no other calls on ANAB in the last 4 months.



There are 4 other peers that have a rating on ANAB. Out of the 4 peers that are also analyzing ANAB, 1 agrees with Anupam's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • John Lee of "Truist Securities" Downgraded from Strong Buy to Hold and Decreased Target to $28 on, Tuesday, September 13th, 2022


These are the ratings of the 3 analyists that currently disagree with Anupam


  • Steven Seedhouse of "Raymond James" Maintained at Buy with Increased Target to $38 on, Wednesday, November 9th, 2022
  • Yatin Suneja of "Guggenheim" Upgraded from Hold to Strong Buy on, Tuesday, November 1st, 2022
  • Gobind Singh of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $35 on, Monday, September 19th, 2022

Contributing Sources